Antidepressants Augment Natural Killer Cell Activity: In vivo and in vitro
- 1 January 1999
- journal article
- clinical trial
- Published by S. Karger AG in Neuropsychobiology
- Vol. 39 (1) , 18-24
- https://doi.org/10.1159/000026555
Abstract
Depressed mood has been associated with reduced natural killer cell activity (NKCA). Further, amelioration of depressive symptoms by pharmacotherapy has resulted in augmented NKCA. Serotonin, an indoleamine implicated in the pathophysiology of affective disorders, enhances NKCA in vitro and lymphocytes possess serotonin transporters and receptors. The present study evaluated NKCA in depressed outpatients before and during treatment with the selective serotonin reuptake inhibitor (SSRI) fluoxetine (Prozac®). Further, the SSRIs, fluoxetine and paroxetine (Paxil®), were also incubated in vitro with lymphoid cells to evaluate possible direct effects of SSRIs on NKCA. Depressed outpatients were administered fluoxetine (20 mg/day) for 4 weeks. NKCA and severity of depression were evaluated at weeks 0, 1, 2, and 4. Serum concentrations of fluoxetine and norfluoxetine were obtained as well. Mononuclear cells obtained from nonpatient volunteers were incubated with pharmacologic concentrations of fluoxetine or paroxetine and NKCA measured with a standard chromium release assay. Fluoxetine treatment resulted in decreased symptoms of depression and increased serum concentrations of fluoxetine and norfluoxetine. Further, fluoxetine treatment was associated with augmented NKCA in a subgroup of depressed outpatients exhibiting low NKCA at baseline. Fluoxetine had no effect on NKCA in depressed individuals exhibiting high NKCA at baseline. Incubation of mononuclear cells with fluoxetine and paroxetine augmented NKCA in vitro. The enhancing effects of antidepressants on NKCA in vivo and in vitro indicate a possible direct drug interaction with lymphoid cells during pharmacotherapy, suggesting that pharmacologic treatment of depression may result in enhanced immune competence as indexed by enhanced NKCA and that NKCA could be pharmacologically augmented with antidepressants in individuals with compromised immune function.Keywords
This publication has 13 references indexed in Scilit:
- HEALTH PSYCHOLOGY: Psychological Factors and Physical Disease from the Perspective of Human PsychoneuroimmunologyAnnual Review of Psychology, 1996
- Expression of a high-affinity serotonin transporter in human lymphocytesInternational Journal of Immunopharmacology, 1994
- A study on the blunted natural killer cell activity in severely depressed patientsLife Sciences, 1992
- Reduced natural killer cell cytotoxicity in depression but not in schizophreniaBiological Psychiatry, 1991
- Depression, natural killer cell activity, and cortisol secretionBiological Psychiatry, 1991
- Reduction of immune function in life stress and depressionBiological Psychiatry, 1990
- Natural killer cell activity in depressive illness: preliminary reportBiological Psychiatry, 1989
- Reduced natural killer cell activity in major depression: neuroendocrine implicationsPsychoneuroendocrinology, 1989
- Lytic effector cell function in schizophrenia and depressionJournal of Neuroimmunology, 1988
- Low natural killer cytotoxicity in major depressionLife Sciences, 1987